Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Schroeder

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Molecular & Cellular Proteomics : MCP|September 12, 2012
Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenograftsHannah Johnson, Amanda M Del Rosario, Bryan D Bryson, et al.
Cancer Biology & Therapy|April 24, 2014
A novel synthetic 1,3-phenyl bis-thiourea compound targets microtubule polymerization to cause cancer cell deathJennifer C Shing, Jae Won Choi, Robert Chapman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 19, 2016
Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative ConditioningArmin Rashidi, John F DiPersio, Peter Westervelt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2016
Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center ReviewArmin Rashidi, John F DiPersio, Peter Westervelt, et al.
Leukemia & Lymphoma|June 18, 2021
A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myelomaLawrence Liu, Mark Fiala, Feng Gao, et al.
Annals of Hematology|September 3, 2024
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myelomaScott R Goldsmith, Michael J Slade, Mark Fiala, et al.
Neuro-Oncology|April 16, 2005
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiformeCaterina Giannini, Jann N Sarkaria, Atsushi Saito, et al.
British Journal of Haematology|June 11, 2022
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host diseaseMichael Pratta, Sophie Paczesny, Gerard Socie, et al.
Annals of Hematology|March 5, 2020
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myelomaScott R Goldsmith, Mark A Fiala, Brandon Wang, et al.
Research Square|October 27, 2023
The Association of Agent Orange (AO) Exposure with Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Progression: A Population-based Study of Vietnam War Era VeteransLawrence W Liu, Mei Wang, Nikhil Grandhi, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Molecular & Cellular Proteomics : MCP|September 12, 2012
Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenograftsHannah Johnson, Amanda M Del Rosario, Bryan D Bryson, et al.
Cancer Biology & Therapy|April 24, 2014
A novel synthetic 1,3-phenyl bis-thiourea compound targets microtubule polymerization to cause cancer cell deathJennifer C Shing, Jae Won Choi, Robert Chapman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 19, 2016
Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative ConditioningArmin Rashidi, John F DiPersio, Peter Westervelt, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2016
Comparison of Outcomes after Peripheral Blood Haploidentical versus Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia: A Retrospective Single-Center ReviewArmin Rashidi, John F DiPersio, Peter Westervelt, et al.
Leukemia & Lymphoma|June 18, 2021
A single center retrospective study of daratumumab, pomalidomide, and dexamethasone as 2nd-line therapy in multiple myelomaLawrence Liu, Mark Fiala, Feng Gao, et al.
Annals of Hematology|September 3, 2024
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myelomaScott R Goldsmith, Michael J Slade, Mark Fiala, et al.
Neuro-Oncology|April 16, 2005
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiformeCaterina Giannini, Jann N Sarkaria, Atsushi Saito, et al.
British Journal of Haematology|June 11, 2022
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host diseaseMichael Pratta, Sophie Paczesny, Gerard Socie, et al.
Annals of Hematology|March 5, 2020
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myelomaScott R Goldsmith, Mark A Fiala, Brandon Wang, et al.
Research Square|October 27, 2023
The Association of Agent Orange (AO) Exposure with Monoclonal Gammopathy of Undetermined Significance (MGUS) to Multiple Myeloma (MM) Progression: A Population-based Study of Vietnam War Era VeteransLawrence W Liu, Mei Wang, Nikhil Grandhi, et al.
Pageof 11